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Summary
Response regulators (RRs), which undergo phos-
phorylation/dephosphorylation at aspartate residues,
are highly prevalent in bacterial signal transduction.
RRs typically contain an N-terminal receiver domain
that regulates the activities of a C-terminal DNA bind-
ing domain in a phosphorylation-dependent manner.
We present crystallography and solution NMR data
for the receiver domain of Escherichia coli PhoB
which show distinct 2-fold symmetric dimers in the
inactive and active states. These structures, together
with the previously determined structure of the C-ter-
minal domain of PhoB bound to DNA, define the con-
formation of the active transcription factor and pro-
vide a model for the mechanism of activation in the
OmpR/PhoB subfamily, the largest group of RRs. In
the active state, the receiver domains dimerize with
2-fold rotational symmetry using their 4-5-5 faces,
while the effector domains bind to DNA direct repeats
with tandem symmetry, implying a loss of intramolec-
ular interactions.
Introduction
Bacteria sense and respond to a wide variety of signals
through a complex network of signaling systems, many
of which are two-component phosphotransfer path-
ways. These systems regulate many processes includ-
ing nutrient uptake, sporulation, chemotaxis, virulence,
quorum sensing, and cell adhesion. They are wide-
spread in bacteria and archea (Volz, 1993), are present
in some fungi (Maeda et al., 1994; Ota and Varshavsky,
1993) and plants (Chang and Meyerowitz, 1994), but
have not been found in animals. Their complete ab-
sence in humans and their involvement in virulence and
antibiotic resistance in bacteria make them attractive*Correspondence: stock@cabm.rutgers.edu
6 Lab address: http://stock.cabm.rutgers.edu/
7 Lab address: http://www-nmr.cabm.rutgers.edu/drug targets. In the simplest form, a two-component
system consists of two modular proteins: a sensory his-
tidine kinase and a response regulator (RR). An environ-
mental signal modulates the activities of the histidine
kinase that undergoes ATP-dependent autophosphory-
lation at a conserved histidine residue. The kinase regu-
lates the activities of its cognate RR by donating its
phosphoryl group to a conserved aspartate in the in-
active RR thus activating it, or by acting as a phospha-
tase and dephosphorylating the active RR. RRs typi-
cally function as DNA binding transcription factors,
although some function as enzymes or as protein-pro-
tein interaction domains. They contain single or multi-
ple domains, often a conserved N-terminal receiver
domain that contains the site of phosphorylation and
a C-terminal effector domain that performs the output
function. The transcription factor RRs are further di-
vided into three major subfamilies, namely OmpR/
PhoB, NarL/FixJ, and NtrC/DctD, based on similarity of
their output domains. The OmpR/PhoB subfamily is the
largest, accounting for 45% of all RRs in Escherichia
coli.
Structural characterization of isolated domains of
RRs has provided insight into function, but a complete
description of the mechanism of phosphorylation-
mediated regulation is lacking. Structures of the con-
served receiver domains of several RRs in both active
and inactive states (Birck et al., 1999; Halkides et al.,
2000; Kern et al., 1999; Lewis et al., 1999) have estab-
lished a common mechanism for the propagation of
phosphorylation-induced conformational changes. Phos-
phorylation at the active site aspartate is accompanied
by reorientation of a few highly conserved residues
leading to allosteric structural perturbations that ex-
tend from the site of phosphorylation to a distant face,
known as the “functional” face of the receiver domain.
Many structures are available for effector domains, and
the fold of the effector domain is known for all three
major classes of RR transcription factors.
Despite the availability of structures for individual do-
mains, it is not clear how phosphorylation of receiver
domains promotes DNA binding and transcriptional ac-
tivation by effector domains in the OmpR/PhoB sub-
family. Two important structural descriptions are lack-
ing. First, there are no structures available for active
proteins in the OmpR/PhoB subfamily, possibly due to
the intrinsic instability of the active site phosho-aspar-
tate bond that poses challenges for crystallization and
NMR studies. Second, little information is available
about the receiver domain–effector domain interfaces
in these proteins due to a paucity of structures of full-
length proteins. Two full-length structures are available
for OmpR/PhoB subfamily members DrrB (Robinson et
al., 2003) and DrrD (Buckler et al., 2002) from the ther-
mophile Thermotoga maritima in the inactive state. In
both proteins, the recognition helices in the DNA bind-
ing domains are completely exposed and sterically un-
hindered by the regulatory domains. This suggests that
the mechanism of phosphorylation-mediated activation
for members of the OmpR/PhoB subfamily may not be
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1354based on phosphorylation-induced relief of steric inhi-
bition as suggested by structures of RRs of other sub-
families (Baikalov et al., 1996; Djordjevic et al., 1998).
We have used NMR and X-ray crystallography to ad-
dress the mechanism of activation of an RR of the
OmpR/PhoB subfamily in the PhoR/PhoB system, a
well-characterized two-component pathway activated
by inorganic phosphate (Pi) limiting conditions (Makino
et al., 1989). PhoR is a histidine protein kinase that
modulates the activities of the RR PhoB in response to
the availability of extracellular phosphate. PhoB is the
master regulator of w39 genes in seven or more oper-
ons and three independent genes which together make
up the Pho regulon. It controls the synthesis of many
proteins for rapid Pi uptake and for utilization of al-
ternate phosphorus sources, including the periplasmic
enzyme alkaline phosphatase and the high-affinity Pi
uptake systems Pst and Ugp. In the absence of PhoR,
PhoB can be crossphosphorylated by the histidine pro-
tein kinase CreC in response to specific catabolites or
phosphorylated directly by acetyl phosphate in a Pi-
independent manner, underscoring its global role in cel-
lular growth and metabolism (Wanner, 1993). PhoB has
also been implicated in crosstalk with other regulatory
proteins involved in antibiotic resistance (Fisher et al.,
1995), virulence (Aoyama et al., 1991), and biofilm for-
mation (Danhorn et al., 2004; Monds et al., 2001).
PhoB is a soluble protein consisting of a 123-residue
N-terminal regulatory domain joined by a 5-residue
linker to a 101-residue C-terminal winged helix DNA
binding domain. PhoB has been reported to exist pri-
marily as a monomer, and phosphorylation greatly en-
hances dimerization (Fiedler and Weiss, 1995; McCleary,
1996). The previously reported crystal structure of the
unactivated regulatory domain (PhoBN) exhibited the
typical receiver domain doubly wound α/β fold with an
unusual placement of helix α4 (Solà et al., 1999). PhoBN
crystallized as a 2-fold symmetric dimer using the α1-
β5-α5 face. The physiological significance of this dimer,
whether reflective of a propensity for dimerization in the
inactive state or indicative of the dimerization interface
promoted by phosphorylation, was unknown. Struc-
tures of the PhoB effector domain (PhoBC) have been
solved by NMR (Okamura et al., 2000) and X-ray crys-
tallography (Blanco et al., 2002), in the free and DNA-
bound forms. Both structures showed a tandem head-
to-tail arrangement of PhoBC consistent with the direct
repeat sequences of pho box DNA recognition half-
sites (Makino et al., 1996).
We report here structural characterization of the re-
ceiver domain of PhoB, which, to our knowledge, is the
first inactive/active receiver domain pair from the OmpR/
PhoB subfamily with distinct structures in the two
states. NMR solution studies together with crystallo-
graphic analyses indicate that both unactivated and ac-
tivated PhoB receiver domains form dimers with 2-fold
rotational symmetry, but that these dimers are distinct
and utilize different dimerization interfaces. Together
with the previously reported structure of the effector
domain bound to DNA (Blanco et al., 2002), these struc-
tures reveal quaternary interactions that define the con-
formation of the active transcription factor and provide
evidence for a mechanism of regulation in which upon
activation, the receiver domains dimerize with 2-fold ro-
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aational symmetry while the effector domains, attached
hrough flexible linkers, bind to pho box DNA recogni-
ion elements in a tandem head-to-tail orientation, im-
lying a loss of orientational constraints between the
wo domains. Based on strict sequence conservation
f the dimerization determinants in the active state, this
odel seems to be conserved throughout the OmpR/
hoB subfamily, and specifically in this subfamily.
esults
he 1-5 Dimer of Inactive PhoBN
he structure of unactivated PhoBN was solved using
xperimental phases from single-wavelength anoma-
ous dispersion (SAD) data at 2.4 Å resolution. There is
ne molecule in the asymmetric unit and it forms a di-
er with another crystallographic symmetry-related
olecule using the face formed by helix α1, the β5-α5
oop, and the N terminus of helix α5 (Figure 1A). The
rotein crystallized in a different space group under dif-
erent conditions than those of the previously solved
tructure (Solà et al., 1999). The current structure has
een refined to an R factor of 0.25. The dimer superim-
oses well with the previous structure with an rms devi-
tion of 1.4 Å for all Cα atoms. This same dimer inter-igure 1. Crystal Structures Show Different Dimers for Inactive and
ctive Regulatory Domains of PhoB
A) Inactive PhoBN dimerizes using the α1-α5 interface. Inactive
hoBN is red; the dimer interface is beige.
B) Active PhoBN dimerizes using the α4-β5-α5 interface. Active
hoBN is green; the dimer interface is blue; and active site ligands
re shown as spheres with magnesium in cyan, beryllium in pink,
nd fluorides in magenta. Figures were created using Pymol (http://
ymol.sourceforge.net/).
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1355face has also been observed in another crystal form of
inactive PhoBN (Solà et al., 1999). The repeated obser-
vation of this dimer interface under different crystalliza-
tion conditions strengthens the hypothesis that the di-
mer is physiologically relevant. Dimerization using this
interface was surprising because dimerization of PhoB
is associated with activation (Fiedler and Weiss, 1995),
and in the majority of receiver domains of other RRs,
the “functional region” undergoing maximum structural
perturbation upon activation is the α4-β5-α5 face.
Solution Studies of Inactive PhoBN
Inactive PhoBN exhibits elution consistent with a 14
kDa monomer during size exclusion chromatography
but shows evidence of weak dimerization by analytical
ultracentrifugation and dynamic light scattering (our
unpublished results). NMR experiments were per-
formed to further characterize the oligomeric state and
symmetry of PhoBN. The theoretical number of cross-
peaks in an HN-15N HSQC (Kay et al., 1992) spectrum
for monomeric 125-residue PhoB receiver domain is
129. The same number of crosspeaks would be ex-
pected for a 2-fold symmetric dimer, as the corre-
sponding residues in the two protomers would have a
similar chemical environment, whereas a significantly
larger number of crosspeaks would be expected for a
dimer without rotational symmetry, as the residues at
the interface in one protomer would have a different
chemical environment than the corresponding residues
in the other protomer. The number of crosspeaks ob-
served in the HSQC spectrum for inactive PhoBN is 124
(Figure 2), consistent with the presence of a monomerFigure 2. HN-15N HSQC Spectra of Inactive and Active Regulatory
Domains of PhoB
The number of peaks observed in the HSQC spectra are 124 and
128 for inactive (red) and active (green) PhoBN, respectively, both
corresponding to monomers or 2-fold symmetric dimers. At NMR
concentrations, both proteins exist as symmetric dimers (see text).
The large differences in the spectra of inactive and active PhoBN
suggest that the structures of the two dimers are significantly dif-
ferent.or a symmetric dimer in solution. This number of HN-15N
amide resonances was confirmed by three-dimensional
HNCO experiments (Muhandiram and Kay, 1994) ruling
out the presence of overlapping peaks.
TROSY-HSQC (Pervushin et al., 1997) spectra were
also recorded at different concentrations of PhoBN (1.5
mM to 0.1 mM). At least nine peaks clearly exhibited
progressive changes in chemical shifts with dilution
(Figure 3), indicating that under these conditions the
domain exhibits an equilibrium between different oligo-
meric states (presumably monomer and dimer). The
presence of a single resonance instead of multiple dis-
tinct resonances through this concentration-dependent
equilibrium demonstrates that this equilibrium is fast on
the NMR timescale (i.e., in the lifetime τ << 100 ms).
The distribution of these oligomeric states was also af-
fected by ionic strength. Increasing the NaCl concen-
tration to 300 mM at 0.5 mM protein concentration
shifted the equilibrium even further toward the form ob-
served at lower protein concentrations (presumably
monomer) than the distribution observed at 100 mM
NaCl for 0.1 mM PhoBN. This illustrates the importance
of solution conditions when quantifying protein-protein
interactions for RRs or other macromolecules with
weak interactions. From these experiments, it was con-
cluded that in solution, unactivated PhoBN exists as a
symmetric dimer in fast equilibrium with a monomer. In
100 mM NaCl at concentrations of PhoBN above 0.75
mM the HSQC pattern is stable, implying that the ma-
jority of the population is in the state favored by higher
protein concentrations, presumably a dimer. Thus at a
concentration of 1 mM PhoBN studied in Figure 2, un-
activated PhoB exists primarily as a 2-fold symmetricFigure 3. Dilution Experiments of Inactive PhoBN
Successive dilutions of inactive PhoBN from 1.5 mM to 0.1 mM
cause a progressive shift in some peaks indicating a fast monomer-
dimer equilibrium on the NMR timescale (i.e., τ << 100 ms). A sec-
tion of the TROSY-HSQC spectrum is shown, with the inset zoomed
on one of the resonances progressively shifting with decreasing
concentration. Crosspeaks for 1.5 mM protein are shown in blue,
for 0.75 mM in green, for 0.375 mM in yellow, and for 0.1 mM in red.N
Structure
1356dimer, consistent with the structure observed by crys-
tallographic analysis.
The 4-5-5 Dimer of Active PhoBN
Beryllium fluoride, a phosphoryl analog (Yan et al.,
1999), was used to generate a stable activated form
of PhoBN for structural studies. BeF3−-activated PhoBN
was crystallized under identical conditions as unacti-
vated PhoBN, except for the presence of BeCl2, MgCl2,
and NaF used to activate the protein. The morphology
and space group of these crystals were different from
those of unactivated PhoBN crystals in spite of identical
crystallization conditions, stressing that the different
crystals in the inactive and active states are not a result
of crystallization conditions, but reflective of changes
caused by activation. The asymmetric unit contains
three PhoBN molecules, two (chains B and C) forming
a 2-fold symmetric dimer using the α4-β5-α5 face (Fig-
ure 1B), and the third (chain A) forming the same dimer
with a crystallographic symmetry-related molecule.
Active Site of Active PhoBN
Density for the Mg2+ and BeF3− complex noncovalently
bound to the active site Asp53 is clearly seen in the
Fobs − Fcalc difference map (Figure 4). The octahedral
coordination of Mg2+ is satisfied by F1 from BeF3−, the
side chain carboxyl oxygens of Asp10 and Asp53, the
main chain carbonyl oxygen of Met55, a water molecule
hydrogen bonded to Asp10, and another water mole-
cule hydrogen bonded to Glu9 and Glu11. The con-
served Lys105 is involved in salt bridges with Glu9, F3
of BeF3−, and a water-mediated bridge with Glu11. The
conserved Thr83 involved in the activation mechanism
in other RRs is in an inward orientation, forming a hy-
drogen bond to the F2 of BeF3−. The rotation of Thr83
is accompanied by a rotation of the backbone N of
the next residue Ala84, which forms a hydrogen bond
with F3.
Conformational Changes in Active PhoBN
The conformation of active PhoBN is similar to the
structures of other activated receiver domains with re-
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fFigure 4. The Active Site of BeF3−-Activated PhoBN
A stereo view of a difference electron density map (Fobs − Fcalc) calculated at 2 Å with omission of the Mg2+, BeF3−, and active site water
molecules from the model is shown in blue, contoured at 3σ. Waters and the catalytic Mg2+ are shown as red and cyan spheres, respectively.
The protein and BeF3− complex are shown in stick representation; beryllium is pink and fluorides are magenta (associations within the
noncovalent BeF3− complex are shown as bonds for clarity).pect to the orientation of key residues involved in the
ropagation of conformational change to the functional
ace and the positioning of secondary structural ele-
ents. Activation at Asp53 at the tip of β3 is accompa-
ied by rotation of residues in the β3-α3 loop and
ovement of α3 toward the active site. The β4-α4 loop
ndergoes major rearrangement, with Arg85, involved
n making contacts with the β5-α5 loop in the unacti-
ated PhoBN structure, undergoing a drastic 180° flip,
nd a displacement of Cα by 6.15 Å. In the structure of
ctive PhoBN, Arg85 is involved in stabilizing interac-
ions with helix α4, forming a salt bridge with Asp90.
he conserved switch residue Tyr102 in β5 rotates from
n inward gauche+ to an inward trans conformation,
oncerted with the inward rotation of Thr83. The main
hain carbonyl oxygen of Arg85 forms a hydrogen bond
ith the OH of Tyr102, which stabilizes the extended
onformation of the β4-α4 loop. These changes are
orrelated with a significant rearrangement in the posi-
ion of helix α4, the β4-α4 loop, and the α4-β5 loop
Figure 5).
The position of helix α4 in the structure of inactive
hoBN is different from that seen in other receiver do-
ain structures. This helix is known to be intrinsically
nstable in other receiver domains such as CheY (Bell-
olell et al., 1994) and NtrC (Volkman et al., 1995), and
ontributes little or nothing to the hydrophobic core of
he protein. In active PhoBN, it adopts a position that
s closer to the structures of other activated receiver
omains. The helix extends from Glu87 to Thr97, as op-
osed to Gly86 to Gly94 in unactivated PhoBN. In acti-
ated PhoBN, helix α4 shifts toward the C terminus and
otates by almost 100°, occupying the space vacated
y rotation of Tyr102 to the trans rotamer. The rotation
f the helix exposes two hydrophobic residues: Val92,
hich is the only residue from α4 that contributes to
he hydrophobic core in the inactive protein, and Ile95.
hese residues, along with the aliphatic portions of
ther residues on the α4-β5-α5 face, comprise a hy-
rophobic patch that is centered within the dimer inter-
ace of the activated protein. The rotation of α4 in the
Dimerization Modes of Inactive and Active PhoB
1357Figure 5. Conformational Changes in PhoBN upon Activation
The greatest conformational changes upon activation occur in the
β4-α4 loop, the α4 helix, and the α5-β5 loop. The important switch
residues Thr83 and Tyr102, residues Ala84 and Arg85 in the β4-α4
loop, residue Asp90 in helix α4, and active site residue Asp53 are
shown in stick representation. The inactive protein is red and the
active protein is green. Active site ligands are shown in ball-and-
stick representation; Mg2+ is cyan, beryllium is pink, and fluorides
are magenta.active protein repositions Arg91, allowing it to partici-
pate in a salt bridge in the dimer.
Solution Studies of Active PhoBN
Active PhoBN exists as a dimer in solution with a Kd
w20-fold less than that of the inactive PhoBN dimer,
as demonstrated by biochemical studies (Fiedler and
Weiss, 1995; McCleary, 1996) and by size exclusion
chromatography and analytical ultracentrifugation (our
unpublished results). The number of crosspeaks ob-
served in the HN-15N HSQC spectrum, and confirmed
by a 3D HNCO experiment, is 128 (Figure 2), consistent
with the 2-fold symmetric dimer seen in the crystal
structure. The HSQC spectrum of PhoBN activated in
the presence of excess ammonium hydrogen phos-
phoramidate and MgCl2 showed an identical pattern of
crosspeaks as that obtained for the BeF3−-activated
protein (data not shown), confirming that BeF3− acts as
a phosphoryl analog to activate PhoB.
Dimer Interface of Active PhoBN
The α4-β5-α5 dimer interface of activated PhoBN buries
a surface area of w890 Å2 per protomer. The interface
is more extensive and polar in composition than the
interface of the inactive dimer which buries w560 Å2,
and is composed primarily of hydrophobic residues.
The interacting surfaces of the inactive protomers form
a small hydrophobic core surrounded by an extensive
network of hydrogen bonds and water bridges. The
interface of active PhoBN is composed of four salt
bridges across the dimer interface (Arg91-Glu111,
Glu96-Lys117, Asp100-Arg122, Asp101-Arg115), three
hydrophobic residues (Val92, Leu95, Ala114) clustered
in a hydrophobic patch, and four hydrogen bonds perprotomer (Figure 6). All of these residues involved in
the salt bridges and hydrophobic patch are completely
conserved in the OmpR/PhoB subfamily and notably,
are not conserved in other RR subfamilies.
Heteronuclear-NOE (Li and Montelione, 1994) spectra
for inactive PhoBN showed at least three arginine HN
resonances that have negative NOEs indicating disor-
dered side chains (Figure 7). Upon activation, all argi-
nine HN resonances become positive, suggesting that
they are ordered. It is likely that these are the arginines
that are involved in the salt bridges at the α4-β5-α5
interface observed in the crystal structure.
Discussion
Activation-Induced Conformational Changes
The extent and nature of structural changes induced
by phosphorylation differ among receiver domains of
different RRs, although most of them undergo pertur-
bation in a common region including the β4-α4 loop
and the α4 helix. NtrC undergoes a substantial change
in the α4 region, involving a register shift as well as
rotation about the helical axis, exposing hydrophobic
residues (Kern et al., 1999). FixJ and DctD undergo rela-
tively small changes tilting α4 away from the active site
(Birck et al., 1999; Park et al., 2002), while Spo0F and
CheY undergo small changes moving α4 toward the
active site (Gardino et al., 2003; Lee et al., 2001). Phos-
phorylation of PhoBN induces conformational changes
similar to those observed in NtrC.
Tyr102, which is one of the key switch residues in
the activation mechanism, has been observed in three
different rotameric states in structures of different re-
ceiver domains. The trans position with an inward ori-
entation, in which the OH group points toward the N
terminus of helix α4, is usually associated with an
active protein. The gauche− (OH points outward from
the domain, exposed to the solvent) and gauche+ (OH
points toward the C terminus of helix α4) conformations
are associated with proteins in the inactive state. In
most cases, the inward gauche+ conformation of tyro-
sine in inactive proteins (Bacillus subtilis PhoP, Birck et
al., 2003; E. coli PhoB, Solà et al., 1999; T. maritima
DrrD, Buckler et al., 2002; E. coli apo-NtrC, Volkman et
al., 1995; Mg2+-bound E. coli CheY, Bellsolell et al.,
1994) is correlated with an unusual position of α4, sig-
nificantly different from its position in the active state
or in the inactive state with tyrosine in the gauche− con-
formation. The two available full-length structures of in-
active OmpR/PhoB subfamily members exhibit dif-
ferent rotameric states of the conserved tyrosine. In
DrrD, the tyrosine exists in a gauche+ conformation and
makes no contact with the C-terminal domain, while in
DrrB, tyrosine is in a gauche− conformation, pointing
outward, and makes extensive contacts including a hy-
drogen bond with a conserved Asp/Asn in the C-ter-
minal domain. The current model of phosphorylation-
induced conformational propagation focuses on two
states characterized by the conserved tyrosine in out-
ward (inactive) or inward (active) positions. The high
correlation between the unusual placement of the in-
trinsically unstable helix α4 and the gauche+ conforma-
tion of the conserved tyrosine switch residue in the in-
Structure
1358Figure 6. Stereo View of the α4-β5-α5 Interface of Active PhoBN
The residues involved in salt bridge and hydrophobic interactions at the interface are completely conserved in, and only in, the OmpR/PhoB
subfamily of response regulators. Residues involved in salt bridges are shown as sticks, and the hydrophobic residues are shown as spheres.
The two protomers of the dimer are colored orange and green. Salt bridges are shown as dotted lines.active state suggests that there is a prevalent third
state, possibly in equilibrium with the other two states.
Relevance of the 1-5 Dimer
Phosphorylation-induced oligomerization is a common
theme in the OmpR/PhoB subfamily of RRs and ap-
pears to provide a mechanism for enhanced DNA bind-
ing and transcriptional regulation. However, the order
and affinity of oligomerization before and subsequent
to phosphorylation varies among subfamily members.
ArcA transitions from a dimer in the inactive state to an
octamer in the active state (Jeon et al., 2001), PmrA is
a dimer in both states (Wösten and Groisman, 1999),
while in the absence of DNA, OmpR does not exhibit
detectable dimerization in either state (Aiba and Mi-
zuno, 1990). PhoBN transitions from a weak dimer to a
tighter dimer upon activation. We have shown that the
inactive and active dimers of PhoBN are distinctly dif-
ferent, a feature that may be specific to PhoB within
the OmpR/PhoB subfamily.
Several factors suggest the relevance of the dimer
of inactive PhoBN observed in the crystal structures.
Previously reported two-hybrid analysis demonstrated
the propensity for interaction of inactive PhoBN do-
mains (Fiedler and Weiss, 1995). Analytical ultracentrif-
ugation (our unpublished results) and concentration-
dependent shift of resonances in NMR experiments
(Figure 3) with unactivated PhoBN both indicate an
equilibrium between monomer and dimer in solution. In
this study, both unactivated and activated PhoBN were
crystallized under similar conditions, ruling out the pos-
sibility that the crystallization conditions selected one
form over the other. Additionally, the same α1-α5 dimer
interface of inactive PhoBN has been observed in three
different crystal forms (Solà et al., 1999). Interestingly,
the inactive regulatory domain of B. subtilis PhoP (Birck
et al., 2003), the ortholog of E. coli PhoB, crystallized
as an asymmetric dimer, distinct from the active state
symmetric dimer that we believe to be common to all
OmpR/PhoB subfamily members. Perhaps alternate in-
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ike” proteins.
The physiological role of the inactive dimer is yet un-
nown. It is important to note that the affinity of the
nactive dimer measured in vitro for inactive PhoBN and
hoB (our unpublished data) is weak, and inconsistent
ith a significant population of dimer in vivo where con-
entrations of PhoB are expected to be in the low
icromolar range. However, it is possible that intracel-
ular macromolecular crowding effects or localization
ue to interactions with DNA and/or the kinase PhoR
ight promote dimerization of inactive PhoB despite
he low affinity estimated in vitro. Furthermore, the ex-
ression of PhoB is autoregulated (Makino et al., 1986;
hinagawa et al., 1983). In phosphate-rich media, the
ntracellular concentration of PhoB is low, favoring an
nactive monomeric state. Upon phosphate starvation,
he intracellular level of PhoB rises. When phosphate-
tarved cells are reintroduced to high phosphate, the
igh concentration of PhoB, at least transiently, may
romote the formation of an inactive dimer, which
ight play an important role in attenuating the phos-
hate response. Thus, the inactive dimer might con-
ribute to an additional, phosphorylation-independent
echanism for downregulation of PhoB-mediated
ene expression.
Dimerization of inactive PhoB might affect its activi-
ies in several different ways. For example, dimerization
ight either enhance or inhibit phosphoryl transfer
rom the dimeric kinase PhoR. Additional effects can
e envisioned if dimerization of the regulatory domains
s considered in the context of the full-length protein.
he domain arrangement in inactive full-length PhoB is
nknown, and the current data are insufficient to pro-
ide an unambiguous model. There are two structures
vailable for inactive proteins in the OmpR/PhoB sub-
amily: DrrB with an extensive interface between the
- and C-terminal domains, and DrrD with a small inter-
ace between the two domains. The inward gauche+ ro-
amer of Tyr102 and the unusual position of helix α4 in
nactive PhoB are consistent with the lack of a domainN
Dimerization Modes of Inactive and Active PhoB
1359Figure 7. HetNOE Spectra of Inactive and Active PhoBN
Negative resonances for HN of arginines in the spectrum of in-
active PhoBN, indicating disordered arginines, become positive
upon activation, indicating order, possibly due to involvement in
salt bridges at the dimer interface of the active protein.
(A) For inactive PhoBN, positive resonances are colored red and
negative resonances are colored blue; for active PhoBN, positive
resonances are colored green and no negative resonances are ob-
served.
(B) One-dimensional slices through the arginine HN region of the
HetNOE spectrum of inactive PhoBN show positive and negative
resonances (top), whereas for activated PhoBN, all arginine HN res-
onances are positive (bottom).interface as observed in DrrD. However, the high de-
gree of conservation of residues that form the central
hydrogen bond at the interdomain interface of DrrB (the
receiver domain switch residue and an Asn/Asp residue
in the effector domain β sheet platform, equivalent to
Tyr102 and Asp140 in PhoB) suggests that a tightly
packed domain interface may be common in inactive
proteins from the OmpR/PhoB subfamily. Whether do-
main orientations in the inactive PhoB dimer are mod-
eled on DrrB or DrrD, the C-terminal domains project in
opposite directions, distant from each other and incom-
patible with binding to direct repeat DNA recognition
elements (Figure 8). This model also suggests that the
inactive dimer might be capable of promoting DNA
looping by binding to distant DNA recognition sites. Ad-
ditionally, formation of the DNA binding–incompetent
α1-α5 dimer might play a role in release of PhoB from
DNA upon dephosphorylation.
Based on the above-described models, the regula-
tory domain could inhibit the effector domain by twomeans: dimerization of the regulatory domains could
provide a means of inhibition of DNA binding in the in-
active protein by orienting the effector domains in op-
posite directions making them incompatible with bind-
ing to DNA direct repeats, or the regulatory domain
could inhibit the effector domain by directly interacting
with it in a DrrB-like fashion, and locking it in a mode
incompatible with tandem DNA binding. It is also pos-
sible that the two domain arrangements represented by
DrrB and DrrD are in equilibrium in the inactive protein
as mentioned earlier.
Model of Phosphorylation-Dependent Activation
Activated PhoBN forms a 2-fold symmetric dimer using
the α4-β5-α5 face. The dimer is similar to that seen for
the receiver domain of MicA (RR02), an OmpR/PhoB
subfamily member which was crystallized in the ab-
sence of an activation agent but is believed to repre-
sent an active state induced by crystallization condi-
tions (Bent et al., 2004). The interface is composed of
several polar and nonpolar residues that are highly con-
served throughout the OmpR/PhoB subfamily, suggest-
ing that this mode of dimerization is common to all
members in this subfamily. Indeed, the same mode of
dimerization is also seen in the structures of activated
receiver domains of T. maritima DrrD, DrrB (V.L. Robin-
son and A.M.S., unpublished results) and E. coli KdpE,
TorR (A. Toro-Roman and A.M.S., unpublished results),
ArcA (Toro-Roman et al., 2005), and PhoP (P.B. and
A.M.S., unpublished results), all from the OmpR/PhoB
subfamily. The only potential exception to this mode of
dimerization reported to date is that postulated for B.
subtilis PhoPN. The receiver domain of B. subtilis PhoP
crystallized using an asymmetric dimer interface in the
inactive state, and the structure was proposed to be
representative of the active state dimer on the basis of
mutational studies in which mutation of an arginine in
helix α5 was shown to disrupt formation of the active
dimer (Birck et al., 2003; Chen et al., 2003). Notably, this
arginine, which corresponds to Arg115 of E. coli PhoB,
is also a crucial part of the 2-fold symmetric α4-β5-
α5 interface of the active OmpR/PhoB dimers, and the
mutation would be expected to disrupt this interface as
well. We believe that the asymmetric dimer observed in
crystals of inactive PhoPN is an alternative inactive
state dimer, structurally distinct from, but perhaps func-
tionally analogous to, the α1-α5 dimer of inactive E. coli
PhoBN. We predict that activated B. subtilis PhoP di-
merizes in a fashion similar to active PhoBN and other
OmpR/PhoB subfamily members.
The structures of the active PhoBN dimer and the
PhoBC dimer bound to DNA together define the active
complex of PhoB bound to DNA, a state we postulate
to be common to most all members of the OmpR/PhoB
subfamily. The DNA binding domain of PhoB binds to
pho box repeats in a tandem head-to-tail fashion, while
the activated receiver domain forms a 2-fold symmetric
head-to-head dimer. This implies an obligatory lack of
interaction between the N- and C-terminal domains
upon activation (Figure 8). Although the majority of DNA
recognition elements to which the members of OmpR/
PhoB subfamily bind have been characterized as tan-
dem repeats, this is a versatile mode of interaction, as
Structure
1360Figure 8. Model of Phosphorylation-Induced Activation in the OmpR/PhoB Subfamily
In the active state, believed to be common to all OmpR/PhoB subfamily members, the receiver domains form a 2-fold symmetric dimer while
the DNA binding domains bind to DNA with tandem symmetry. Inactive PhoB exists in equilibrium between a monomer and dimer. The
inactive α1-α5 dimer, specific to PhoB, provides an additional means of inhibition by positioning the effector domains in opposite directions,
incompatible with tandem DNA binding. Inactive PhoBN is shown in red, active PhoBN in green, the α1-α5 interface of the inactive dimer in
beige, the α4-β5-α5 interface of the active dimer in blue, the DNA binding domain in gray, and the recognition helix in pink. Full-length inactive
PhoB was modeled by positioning the two domains of PhoB as they exist in the structure of DrrB.DNA sequence or protein-protein interaction specificity
Table 1. Data Collection and Refinement Statistics
Crystal Data Inactive PhoBN Active PhoBN
Wavelength (Å) 1.07177 0.97176
Space group P6122 P43212
Cell dimensions
a, b, c (Å) 60.86, 60.86, 152.05 77.87, 77.87,
109.07
α, β, γ (°) 90, 90, 120 90, 90, 90
Resolution (Å) 30–2.4 30–1.9
Rsymb 0.09 (0.50)a 0.08 (0.64)
I/σI 22.41 (5.5) 18.4 (2.8)
Completeness (%) 99.3 (97.6) 93.7 (86.4)
Redundancy 14.36 (12.65) 11.7 (5.5)
Refinement
Resolution (Å) 30–2.4 30–1.9
No. reflections 10,832/1,189 19,432/2,135
(work/test)
Rc/Rfree 0.25/0.29 0.19/0.24
No. atoms
Protein 957 2,850
Ligand/ion 3 15
Water 0 180
B factors
Protein 45.97 23.448
Ligand/ion 78.0 40.47
Water — 32.35
Rms deviations
Bond lengths (Å) 0.0092 0.0155
Bond angles (°) 2.54 1.56
a Numbers for highest resolution bin are shown in parentheses.
b Rsym = S|I − <I>|/SI, where I = observed integrated intensity and
<I> = average integrated intensity obtained from multiple mea-
surements.
c R = S||Fo| − |Fc||/S|Fo|, where |Fo| and |Fc| are the observed and
calculated structure factor amplitudes, respectively; Rfree is
equivalent to R, but is calculated using a 10% disjoint set of
reflections set aside prior to refinement.
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oa flexible tether linking the domains would allow the
effector domains to bind to DNA in any orientation,
either head-to-tail or head-to-head, as dictated by the
b
t
between effector domains. While intramolecular in-
eractions between receiver and effector domains may
e an important mode of regulation in the inactive pro-
eins, intermolecular interactions, specifically promo-
ion of dimer formation, may be the sole function of the
hosphorylated receiver domains in OmpR/PhoB tran-
cription factors.
xperimental Procedures
loning
he DNA sequence encoding PhoBN was amplified using PCR from
ull-length PhoB plasmid pT7PhoB obtained from W.R. McCleary
McCleary, 1996). This DNA fragment was inserted into the Nde1
nd BamH1 restriction sites of the T7-based vector pJES307 to
ield plasmid pEF28. The plasmid was amplified in E. coli strain
H5α purified and transformed into E. coli BL21 (DE3). The se-
uence encodes a 125-residue protein consisting of residues 1–
24 from the PhoB sequence and a Gln residue at the C terminus.
verexpression and Purification
or unlabeled protein, cells were grown in Luria-Bertani (LB) me-
ium supplemented with 100 g/ml of ampicillin at 37°C to midlog-
rithmic phase. PhoBN expression was induced with 0.5 mM IPTG
or 3 hr at 37°C. To obtain 15N- and 13C-labeled proteins for NMR
tudies, transformed cells were grown in isotope-enriched MJ9
edium (Jansson et al., 1996) containing 0.15% w/v (15NH4)2SO4
or 15N-labeling experiment or 0.15% w/v (15NH4)2SO4 and 0.4%
/v 13C-glucose for 15N, 13C-enrichment, and shaken at 37°C to an
D600 of 0.8 to 1.0. The cells were then induced in the late-logarith-
ic phase with 1 mM IPTG and shaken at 17°C overnight. For the
elenomethionine-derivatized PhoBN, the plasmid was transformed
nto a methionine auxotroph strain, and grown as described pre-
iously (Hendrickson et al., 1990). The cells were harvested by cen-
rifugation for 30 min at 5,000 × g, resuspended in buffer A (50
M Tris-HCl [pH 8.0] and 2 mM βME), and centrifuged again. All
ubsequent steps were carried out at 4°C. Cells were resuspended
n buffer A and lysed by sonication. The lysate was centrifuged at
5,000 × g for 1 hr to remove cell debris. The supernatant was
hen subjected to fractionation at 30% saturated (NH4)2SO4, which
recipitated >95% of PhoBN along with other proteins. The precipi-
ate was harvested and solubilized in buffer A, then dialyzed over-
ight against buffer A. The protein was filtered and applied to 5 ml
r 70 ml HiTrap Q HP columns (Amersham Biosciences, Piscata-
Dimerization Modes of Inactive and Active PhoB
1361way, NJ) preequilibrated with buffer A. PhoBN was eluted using a
three-column volume gradient from 0 to 1 M NaCl. The fractions
containing PhoBN were pooled, concentrated, and loaded on a
Superdex 75 26/60 (Amersham Biosciences) column. The column
was equilibrated and run with 50 mM Tris-HCl (pH 8.0), 100 mM
NaCl, 5 mM βME for unlabeled protein, 50 mM Tris-HCl (pH 8.0),
100 mM NaCl, 10 mM βME for selenomethionine-labeled protein,
and 20 mM MES (pH 6.5), 100 mM NaCl, 5 mM βME for 15N- and
15N, 13C-labeled proteins. Fractions containing PhoBN were pooled,
and the purity was assessed by Coomassie blue staining subse-
quent to SDS-PAGE. The protein was >95% pure.
Activation of PhoBN
PhoBN was activated by adding 5.3 mM BeCl2 (Sigma-Aldrich, St.
Louis, MO), 35 mM NaF, and 7 mM MgCl2 to 1 mg/ml protein, and
concentrating it to the desired concentration using an Amicon ul-
tracentrifugal filtration device, MW cutoff 10 kDa (Millipore, Biller-
ica, MA). The activation by ammonium hydrogen phosphoramidate
(AHP) was achieved by adding 50 mM AHP and 20 mM MgCl2 to
1 mg/ml protein and incubating for 30 min at room temperature.
NMR Data Collection and Processing
NMR samples were prepared in 20 mM MES (pH 6.5), 100 mM NaCl,
5 mM βME, 5% D2O, and 95% H2O. NMR data were collected at
20°C on a Varian Unity Inova 600 MHz spectrometer equipped with
5 mm triple-resonance probes with z-axis-pulsed magnetic field
gradients (Varian, Palo Alto, CA). Protein concentrations ranged
from 0.1 to 1.5 mM. The NMR data were analyzed and processed
using the programs NMRPipe (Delaglio et al., 1995) and NMRDraw
(Delaglio et al., 1995). Sparky version 3.1 (http://www.cgl.ucsf.edu/
home/sparky) was used for peak picking and interactive spectral
analysis.
Crystallization and Structure Determination
Initial conditions for inactive and active PhoBN crystallization were
identified using PEG/Ion Screen (Hampton Research, Aliso Viejo,
CA). After optimization, crystals were obtained by the hanging drop
method for selenomethionine-derivatized and native inactive
PhoBN and BeF3−-activated PhoBN by mixing equal volumes of
protein solution at 20 mg/ml concentration and reservoir solution
(25% PEG 3350 and 0.2 M NaSCN) and incubating at room temper-
ature. Crystals appeared in 2 days. The inactive PhoBN crystals
were cryoprotected by transferring the crystals to a solution con-
taining 30% PEG 3350, 0.2 M NaSCN, 7% glycerol, and 15% ethyl-
ene glycol (cryo1), and flash-freezing them directly in a 100 K nitro-
gen cryostream. The cryoprotectant for the active PhoBN crystals
contained cryo1 + 2% sucrose + 5.3 mM BeCl2, 35 mM NaF, and
7 mM MgCl2 (to maintain full occupancy of BeF3− in the frozen
crystals).
For selenomethionine-derivatized inactive PhoBN crystals, multi-
wavelength anomalous dispersion (MAD) data were collected at
X4A beamline at the National Synchrotron Light Source (Brookha-
ven National Laboratory, Upton, NY) at selenium peak anomalous,
inflexion, and high-energy remote wavelengths based on XAFS
scans, but no selenium sites could be found due to weak anoma-
lous signal. The selenomethionine-derivatized crystals were then
soaked in 5 mM K2PtCl4 in cryo1 for 30 min and flash-frozen. Sin-
gle-wavelength anomalous dispersion (SAD) data were collected at
the Pt peak wavelength (1.07177 Å) based on an XAFS scan. The
crystals belong to the space group P6122 with unit cell dimensions
of a = b = 60.861 Å, c = 152.047 Å, corresponding to one molecule
of inactive PhoBN per asymmetric unit. Data were processed and
scaled with Denzo (Otwinowski and Minor, 1997) and Scalepack
(Otwinowski and Minor, 1997). Three Pt sites were clearly identified
using SAD phasing protocol in Crystallography and NMR System
software suite (CNS; Brünger et al., 1998) using data to 2.5 Å.
Phase ambiguity was resolved with maximum likelihood density
modification by solvent flipping in CNS, which yielded excellent
quality electron density maps. The model was built manually in
XtalView (McRee, 1999) interspersed with iterative cycles of refine-
ment by positional refinement and simulated annealing in CNS. The
model was only partially refined to final resolution of 2.4 Å and hasRcryst/Rfree = 0.25/0.29. It contains 122 amino acids, 3 Pt atoms,
and 6 water molecules.
Data were collected for native crystals of BeF3−-activated PhoBN
at 0.97176 Å wavelength. The crystals belong to space group
P43212 with unit cell dimensions of a = b = 77.869 Å, c = 109.071 Å,
corresponding to three molecules of active PhoBN per asymmetric
unit. The structure was solved using data from 15 to 3 Å by molecu-
lar replacement using Phaser (Storoni et al., 2004) integrated with
the CCP4i (CCP4, 1994) interface, using the structure of inactive
PhoBN without the loops, helix α4, and strand β5 as the search
model. The model was converted to an alanine model by removing
all the side chains and was manually rebuilt by iterative cycles of
simulated annealing, positional refinement, temperature factor re-
finement, and rebuilding using XtalView, CNS version 1.1, and
Refmac 5.2.0005 (Murshudov et al., 1997) until convergence.
Noncrystallographic symmetry (NCS) was used for density modifi-
cation and for removing model bias in the initial cycles of refine-
ment until the Rcryst dropped to 24%, after which the three protein
chains (A, B, and C) were built individually. The final model was
refined to 1.9 Å and has Rcryst/Rfree = 0.19/0.24. The final model
contains 359 amino acids, 3 BeF3− ions, 3 Mg2+ atoms, and 180
water molecules (see Table 1 for details). Residues 44 and 45 in
chain B in the α2-β3 loop were not built due to poor density in the
region. From PROCHECK analysis, 94% of the residues appear in
most favorable regions, and 6% occur in allowed regions. Figures
were created using Pymol (http://pymol.sourceforge.net). Chain A
was used for making all figures, except Figure 6 in which the inter-
face shown is between chains B and C. The salt bridge between
Glu96 and Lys117 was not observed in the dimer formed by chain A.
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